{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T12:24:04Z","timestamp":1781007844081,"version":"3.54.1"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>An 18-year-old man with newly diagnosed Burkitt lymphoma\/leukemia was referred for <jats:sup>18<\/jats:sup>F-FDG and <jats:sup>68<\/jats:sup>Ga-Pentixafor PET\/CT. <jats:sup>68<\/jats:sup>Ga-Pentixafor PET\/CT revealed similar radioactivity uptake pattern to the <jats:sup>18<\/jats:sup>F-FDG PET\/CT in superior phrenic lymph node, ascending colon, ileocecum, peritoneal, marrow, and spleen. This case highlighted that it might be interesting to further investigate the role of <jats:sup>68<\/jats:sup>Ga-Pentixafor PET\/CT imaging in staging, treatment evaluation, and especially the feasibility of CXCR4-directed radioligand therapy in Burkitt lymphoma with positive expression of CXCR4.<\/jats:p>","DOI":"10.1097\/rlu.0000000000003750","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T21:07:25Z","timestamp":1623445645000},"page":"98-100","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Burkitt Lymphoma\/Leukemia Presented on 68Ga-Pentixafor and 18F-FDG PET\/CT"],"prefix":"10.1097","volume":"47","author":[{"given":"Zhenying","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobo","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibing","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,6,11]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13550-020-00681-7","article-title":"Preliminary evidence of imaging of chemokine receptor-4-targeted PET\/CT with [68Ga]Pentixafor in non-Hodgkin lymphoma: comparison to [18F]FDG","volume":"10","year":"2020","journal-title":"EJNMMI Res"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"618","DOI":"10.7150\/thno.11251","article-title":"Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging","volume":"5","year":"2015","journal-title":"Theranostics"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/RLU.0000000000002923","article-title":"Posttreated POEMS syndrome with concurrent follicular lymphoma revealed by 18F-FDG and 68Ga-Pentixafor PET\/CT","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00259-019-04605-z","article-title":"Chemokine receptor-4 targeted PET\/CT with 68Ga-Pentixafor in assessment of newly diagnosed multiple myeloma: comparison to 18F-FDG PET\/CT","volume":"47","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"932","DOI":"10.3324\/haematol.2016.142976","article-title":"Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemia","volume":"101","year":"2016","journal-title":"Haematologica"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/RLI.0000000000000469","article-title":"[68Ga]Ga-Pentixafor PET\/MRI for CXCR4 imaging of chronic lymphocytic leukemia: preliminary results","volume":"53","year":"2018","journal-title":"Invest Radiol"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.7150\/thno.19119","article-title":"[177Lu]pentixather: comprehensive preclinical characterization of a first CXCR4-directed endoradiotherapeutic agent","volume":"7","year":"2017","journal-title":"Theranostics"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2967\/jnumed.115.167361","article-title":"First-in-human experience of CXCR4-directed endoradiotherapy with 177Lu- and 90Y-Labeled pentixather in advanced-stage multiple myeloma with extensive intra- and extramedullary disease","volume":"57","year":"2016","journal-title":"J Nucl Med"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.7150\/thno.19050","article-title":"CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed multiple myeloma","volume":"7","year":"2017","journal-title":"Theranostics"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2967\/jnumed.118.210997","article-title":"Feasibility of CXCR4-directed radioligand therapy in advanced diffuse large B-cell lymphoma","volume":"60","year":"2019","journal-title":"J Nucl Med"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"369","DOI":"10.7150\/thno.21397","article-title":"Dual targeting of acute leukemia and supporting niche by CXCR4-directed theranostics","volume":"8","year":"2018","journal-title":"Theranostics"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2967\/jnumed.118.223420","article-title":"Side effects of CXC-chemokine receptor 4-directed endoradiotherapy with pentixather before hematopoietic stem cell transplantation","volume":"60","year":"2019","journal-title":"J Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003750","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:07:38Z","timestamp":1750536458000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,11]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003750","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,11]]}}}